Effectiveness of mouse minute virus inactivation by high temperature short time treatment technology: A statistical assessment
Abstract
Viral contamination of mammalian cell cultures in GMP manufacturing facility represents a serious safety threat to biopharmaceutical industry. Such adverse events usually require facility shutdown for cleaning/decontamination, and thus result in significant loss of production and/or delay of product development. High temperature short time (HTST) treatment of culture media has been considered as an effective method to protect GMP facilities from viral contaminations. Log reduction factor (LRF) has been commonly used to measure the effectiveness of HTST treatment for viral inactivation. However, in order to prevent viral contaminations, HTST treatment must inactivate all infectious viruses (100%) in the medium batch since a single virus is sufficient to cause contamination. Therefore, LRF may not be the most appropriate indicator for measuring the effectiveness of HTST in preventing viral contaminations. We report here the use of the probability to achieve complete (100%) virus inactivation to assess the effectiveness of HTST treatment. By using mouse minute virus (MMV) as a model virus, we have demonstrated that the effectiveness of HTST treatment highly depends upon the level of viral contaminants in addition to treatment temperature and duration. We believe that the statistical method described in this report can provide more accurate information about the power and potential limitation of technologies such as HTST in our shared quest to mitigate the risk of viral contamina…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
At the end of Q3 2019, more than 1,052 advanced therapy medicinal products (ATMPs) were being tested in phase I-III clinical trials and several cell and gene therapies had received regulatory approval.
“At the end of Q3, 2019, more than 1,052 advanced therapy medicinal products (ATMPs) were being tested in phase I-III clinical trials (https://alliancerm.org/publication/q3-2019-data-report/) and several cell 45 and gene 46 therapies had received regulatory approval.”
From Viral contamination in biologic manufacture and implications for emerging therapies (2020) · cites this paper as [45]
Cited by
Sorted by citations
Viral contamination in biologic manufacture and implications for emerging therapies
Barone, P. W., Wiebe, M. E., Leung, J. C., Hussein, I. T. M., Keumurian, F. J., Bouressa, J., Brussel, A., Chen, D., Chong, M., Dehghani, H., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0507-2 · Cited by 212 · see citing works
Self-citation
- Authors
- Murphy, M., Quesada, G. M., & Chen, D.
- Affiliations
- Eli Lilly (United States) (US)
- Corresponding author
- Chen, Dayue
- ORCID
- Chen, Dayue
- Venue
- Biologicals
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 39
- Issue
- 6
- Pages
- 438-443
- ISSN
- 1045-1056 (ISSN-L)
- OpenAlex
- W1974068274
- Cited by
- 22
- References
- 0
- Citations by year
- 2025: 1 · 2022: 1 · 2021: 2 · 2020: 2 · 2018: 4 · 2017: 4 · 2014: 1 · 2013: 5 · 2012: 1
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biologicals (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Microbial Inactivation Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Immunology and Microbiology › Microbiology › Medical Device Sterilization and Disinfection
- Keywords
- high-temperature short-time treatment, virus inactivation
- MeSH terms
- Algorithms, Animals, Cell Line, Culture Media, Disinfection, Drug Contamination, Hot Temperature, Humans, Kinetics, Minute Virus of Mice, Technology, Pharmaceutical, Time Factors, Virus Replication, Reproducibility of Results, Virus Inactivation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review